BridgeBio Pharma, Inc. (BBIO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BBIO currently has 195M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 5.11% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 194.8M shares outstanding |
190M | 0 |
| Jan 21, 2026 |
8-K filing: BridgeBio Pharma, Inc. issued $632.5 million in Convertible Senior Notes and used $82.5 million to repurchase 1,081,825 shares of its common stock. ($82.5M proceeds) |
190M | 0 |
| Oct 29, 2025 |
10-Q filing | 191.9M shares outstanding |
190M | 0 |
| Aug 05, 2025 |
10-Q filing | 190.5M shares outstanding |
190M | 0 |
| Apr 29, 2025 |
10-Q filing | 190.1M shares outstanding |
190M | 0 |
| Feb 20, 2025 |
10-K filing | 186.1M shares outstanding |
190M | 0 |
| Nov 12, 2024 |
10-Q filing | 188.5M shares outstanding |
190M | 0 |
| Aug 01, 2024 |
10-Q filing | 187.6M shares outstanding |
190M | 0 |
| May 02, 2024 |
10-Q filing | 178.7M shares outstanding |
180M | 0 |
| Mar 06, 2024 |
8-K filing: BridgeBio Pharma, Inc. entered into an Underwriting Agreement for a public offering of 8,620,690 shares of common stock at $29.00 per share, with an option for the underwriters to purchase an additional 1,293,103 shares, expected to close on or about March 8, 2024. ($250.0M proceeds) |
160M | 0 |
| Feb 22, 2024 |
10-K filing | 162.8M shares outstanding |
160M | 0 |
| Nov 02, 2023 |
10-Q filing | 163.3M shares outstanding |
160M | 0 |
| Sep 25, 2023 |
8-K filing: BridgeBio Pharma, Inc. entered into a securities purchase agreement to sell and issue 9,167,723 shares of common stock at $27.27 per share in a private placement, expecting gross proceeds of approximately $250 million. ($250.0M proceeds) |
160M | 0 |
| Aug 03, 2023 |
10-Q filing | 160.5M shares outstanding |
160M | 0 |
| May 04, 2023 |
10-Q filing | 152.6M shares outstanding |
150M | 0 |
| Feb 23, 2023 |
10-K filing | 147.5M shares outstanding |
150M | 0 |
| Nov 03, 2022 |
10-Q filing | 147.9M shares outstanding |
150M | 0 |
| Aug 04, 2022 |
10-Q filing | 146.7M shares outstanding |
150M | 0 |
| May 05, 2022 |
10-Q filing | 147.7M shares outstanding |
150M | 0 |
| Feb 25, 2022 |
10-K filing | 147.6M shares outstanding |
150M | 0 |
| Nov 04, 2021 |
10-Q filing | 147.2M shares outstanding |
150M | 0 |
| Aug 05, 2021 |
10-Q filing | 149.8M shares outstanding |
150M | 0 |
| May 06, 2021 |
10-Q filing | 149.3M shares outstanding |
150M | 0 |
| Feb 25, 2021 |
10-K filing | 149.0M shares outstanding |
150M | 0 |
| Nov 05, 2020 |
10-Q filing | 122.6M shares outstanding |
120M | 0 |
| Aug 11, 2020 |
10-Q filing | 122.4M shares outstanding |
120M | 0 |
| May 14, 2020 |
10-Q filing | 121.4M shares outstanding |
120M | 0 |
| Mar 03, 2020 |
10-K filing | 123.8M shares outstanding |
120M | 0 |